Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Outi Mäki-Ikola"'
Publikováno v:
Clinical Neuropharmacology. 23:22-27
The goal of this study was to examine the multiple-dose pharmacokinetics of selegiline and its metabolites desmethylselegiline, 1-methamphetamine, and 1-amphetamine after oral administration of selegiline HCl. Twelve healthy volunteers received 10 mg
Publikováno v:
Arthritis & Rheumatism. 41:1054-1063
Objective. To investigate the adhesion and extravasation capacity of peripheral blood mononuclear cells (PBMC) and the transport of bacterial antigens within these cells during Salmonella infection. Methods. Thirteen patients who were part of 2 outbr
Autor:
Esa Heinonen, Kari Laine, Antti Helminen, Risto Huupponen, Kari Reinikainen, Markku Anttila, Mika Scheinin, Outi Mäki-Ikola
Publikováno v:
Clinical Neuropharmacology. 20:419-433
We have evaluated the risk for pharmacokinetic and/or pharmacodynamic interactions of concomitantly administered selegiline, a selective monoamine oxidase type B inhibitor, and citalopram, a widely used selective serotonin uptake inhibitor antidepres
Publikováno v:
Annals of the Rheumatic Diseases. 56:180-183
OBJECTIVES—A role for Klebsiella pneumoniae in ankylosing spondylitis (AS) has been suggested because faecal carriage of Klebsiella and serum Klebsiella specific antibodies may be increased in this disease. This study has extended the earlier findi
Publikováno v:
Annals of the Rheumatic Diseases. 54:631-635
OBJECTIVE--To study further the Klebsiella specific serum antibody response in patients with axial and peripheral types of ankylosing spondylitis (AS). METHODS--IgA1 and IgA2 subclass antibodies to Klebsiella pneumoniae were measured by enzyme linked
Autor:
Outi Mäki-Ikola, Jürgen Heesemann, Auli Toivanen, Kaisa Granfors, R Merilahti-Palo, Riitta Lahesmaa, R. Saario
Publikováno v:
Annals of the Rheumatic Diseases. 53:535-539
OBJECTIVES--To further evaluate the role of bacterial antigens in triggering inflammation in the joint in patients with reactive arthritis by studying local antibody synthesis in the joint. METHODS--Yersinia-specific antibodies in paired serum and sy
Publikováno v:
Journal of Infectious Diseases. 163:409-412
An ELISA for the screening of serum antibodies to Yersinia species was developed using plasmid-encoded released proteins of Yersinia enterocolitica O:8 and lipopolysaccharide of Y. enterocolitica O:3 as a combined antigen. Of 43 sera from patients in
Autor:
Jukka Penttinen, Auli Partanen, Ulla Lepola, Juha Rouru, Harri Kanerva, Tiina Pohjalainen, Hannu Koponen, Riitta H. Jokinen, Roope Raassina, Leena Lehtonen, Antti Ahokas, Outi Mäki-Ikola, Hannu Naukkarinen
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 15(6)
Deramciclane, a camphor derivative, is a novel anxiolytic agent with a unique mechanism of action. It acts as a potent and specific antagonist at serotonin 5-HT2A/2C receptors, and exhibits anxiolytic efficacy in animal models. The aim of this double
Autor:
Riitta Lahesmaa, M Pulz, R. Saario, Kaisa Granfors, Outi Mäki-Ikola, Jürgen Heesemann, Auli Toivanen
Publikováno v:
Annals of the Rheumatic Diseases. 51:1247-1249
Using an inhibition enzyme linked immunosorbent assay (ELISA) the serum antibody responses against released proteins of yersinia of molecular weights 26 and 46 kilodaltons were studied in 37 patients with and in 21 patients without reactive arthritis
OBJECTIVE—To measure gut immunity directly in jejunal fluid in patients with ankylosing spondylitis (AS) and rheumatoid arthritis (RA). METHODS—Antibodies against three different Enterobacterias were measured in jejunal perfusion fluids (collecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03aa9a71a642ef847750c232d4964739
https://europepmc.org/articles/PMC1752411/
https://europepmc.org/articles/PMC1752411/